Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1 - PubMed (original) (raw)
Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1
Ping Yi et al. Mol Cell. 2008.
Abstract
SRC-3/AIB1 is a steroid receptor coactivator with potent growth-promoting activity, and its overexpression is sufficient to induce tumorigenesis. Previous studies indicate that the cellular level of SRC-3 is tightly regulated by both ubiquitin-dependent and ubiquitin-independent proteasomal degradation pathways. Atypical protein kinase C (aPKC) is frequently overexpressed in cancers. In the present study, we show that aPKC phosphorylates and specifically stabilizes SRC-3 in a selective ER-dependent manner. We further demonstrate that an acidic residue-rich region in SRC-3 is an important determinant for aPKC-mediated phosphorylation and stabilization. The mechanism of the aPKC-mediated stabilization appears due to a decreased interaction between SRC-3 and the C8 subunit of the 20S core proteasome, thus preventing SRC-3 degradation. Our results demonstrate a potent signaling mechanism for regulating SRC-3 levels in cells by coordinate enzymatic inhibition of both ubiquitin-dependent and ubiquitin-independent proteolytic pathways.
Figures
Fig. 1
aPKC stabilizes SRC-3 protein. (A) Flag-SRC-3 and ERα expression vectors were co-transfected with HA tagged kinase expression vectors into HeLa cells. (B) Western blot analysis of flag-SRC-3 protein level when cells were co-transfected with constitutively active mutant of PKCζ (A119E) or PKCι (A120D), or their kinase dead mutants (K281W and K274W, respectively). (C) RT-PCR was performed using flag-specific primer and SRC-3-specific primer to detect the mRNA level of transfected flag-SRC-3. A RT-PCR experiment without the addition of reverse transcriptase (RT) was included as a control. (D) Pulse-chase experiment. HeLa cells were transfected with flag-SRC-3 and ERα, with or without co-transfection of PKCζ. Shown is autoradiograph of flag-SRC-3 immunoprecipitated from cell lysates. (E) PKCζ stabilizes SRC-3 protein in proteasome-mediated degradation pathway. Cells were treated with proteasome inhibitor MG132 or vehicle DMSO for 16 hrs. (F) Endogenous SRC-3 and PKCζ protein levels in MCF-7 cells treated with siPKCζ. (G) Real time qRT-PCR was carried out to detect the mRNA level of endogenous SRC-3. (H) Overexpression of PKCι rescued the siRNA knock-down effect on SRC-3 protein level. Details were described in Supplemental Procedures.
Fig. 2
Estrogen and estrogen receptor are required for the aPKC stabilization effect (A) Effects of active PKCζ on SRCs in the presence of ERα. (B) Effects of active PKCζ on flag-SRC-3 protein level in the absence or presence of flag-ERα, or flag-PRB. (C) E2 increases PKCζ mediated stabilization effect. WT: wild type PKCζ, CAT: constitutively active mutant, DM: kinase dead mutant. (D) PKCζ interacts with both SRC-3 and ERα. Cells were transfected with V5- PKCζ and flag-SRC-3 or flag-ERα. Cell lysates were immunoprecipitated by anti-flag antibody or normal IgG and Western blot analysis was performed using anti-V5 antiobody. (E) Effects of different ERα mutants on the PKCζ mediated stabilization effect. ERΔAF1: deletion of 1–178 amino acids; ERAF2m: K362D/V376D/L539A; ER(cyto)m: deletion of 250–303 amino acids. (F) Coimmunoprecipitation experiment detecting the interaction between PKC and different ERα mutants. (G) PKCζ has significantly reduced stabilization effect on SRC-3 AAA mutant. (H) Autoradiograph of in vitro PKCζ kinase assay detecting phosphorylation of purified recombinant SRC-3 by incorporation of γ-32P ATP in the absence and presence of purified ERα and estrogen.
Fig. 3
PKCζ enhances SRC-3 coactivator activity. (A) PKCζ enhances SRC-3 activated ER targeted gene transcription. HeLa cells were transfected with ERα, SRC-3, PKCζ or its mutants in the absence or presence of E2. The transcription of pS2 gene was measured by real time qRT-PCR (left panel). The expression levels of PKCζ and its mutants were shown in the right panel. (B) aPKC stabilized SRC-3 is transcriptionally active in cell-free transcription assay. Plasmid ERE-E4 was assembled into chromatin and transcribed as described in Materials and Methods. ER and E2 were added in the reaction. Triangles represent increasing amounts of purified flag-SRC-3 (1.5, 9 and 37.5 ng SRC-3 protein, respectively) from HeLa cells without (−PKCζ) or with (+PKCζ) cotransfection of active PKCζ. The relative level of E4 transcript was measured using real time qPCR (left panel). Right panel: comparable amounts of flag-SRC-3 (−PKCζ or +PKCζ, 9 ng protein) were used in the assay by Western blot analysis. Error bars indicate the standard error of the means from three independent experiments.
Fig. 4
Identification of an important region in SRC-3 for aPKC stabilization effect (A) Effects of aPKC on SRC-3 A1-6 mutant (B) Effects of aPKC on SRC-3 deletion mutants (C) Effects of aPKC on SRC-3 mutants with deletion within the region of 1031–1130 (D) Effects of aPKC on SRC-3 mutants with Ser/Thr-Ala mutations within the region of 1031–1130. Details of the mutants were described in Supplemental Procedures. (E) Protein stability of SRC-3 wild type and the mutants as assayed by treating cells with 200 µg/ml cycloheximide at indicated time period. Shown in the left panel is the Western blot analysis of flag-SRC-3 protein. The right panel shows the quantification of protein intensity. (F) Amino acid sequences of SRC-3 1031–1097 (bolded) and the surrounding sequences. Acidic residues are in larger fonts. Ser/Thr residues are in Italic and shadowed. (G) L5A mutation (shown underlined in panel A) significantly reduced aPKC stabilization effect. (H) D/E8K/R mutation (shown underlined in panel A) significantly reduced aPKC stabilization effect.
Fig. 5
aPKC stabilizes SRC-3 by preventing interaction with the 20S proteasome C8. (A) SRC-3 interacts with GST-C8. 293T cells were transfected with flag-SRC-3 and ERα. Cell lysates were incubated with GST fusion proteins and the bound flag-SRC-3 was detected by Western blot. Upper panel: Western blot analysis of flag-SRC-3 pulled-down by GST fusion proteins. Lower panel: Coomassie staining of GST and GST fusion proteins. (B) GST-PSMA7 is a functional protein. In vitro transcribed and translated HA-HIF-1α was incubated with GST or GST-PSMA7 and the bound HA-HIF-1α was detected by anti-HA antibody. (C) PKCζ decreases the interaction between SRC-3 and GST-C8. (D) D/E8K/R mutation or deletion of 1031–1130 in SRC-3 abolishes the effect of PKCζ on the interaction between SRC-3 and C8. (E) PKCζ decreases the interaction between endogenous SRC-3 and C8 in 293T cells. (F) Knocking-down of C8 protein in MCF-7 cells increases the SRC-3 protein level. (G) p21-SRC-3(1028–1099) has weaker interaction with C8. GST-C8 pull-down experiment was carried out using in vitro synthesized p21-SRC-3(1028–1099) and p21-SRC-3(1101–1172) fusion proteins. The bound proteins were detected using anti-p21 antibody. (H) SRC-3 1028–1099 region increased the stability of p21. HeLa cells were transfected with p21, p21-SRC-3(1028–1099) and p21-SRC-3(1101–1172), respectively, and cells were treated with 200µg/ml cycloheximide at an indicated time period one day after transfection. Shown are Western blot analyses using anti-p21 antibody.
Fig. 6
PKCζ protects SRC-3 from proteasome mediated degradation. (A) in vitro 26S proteasome degradation assay. Detailes were described in Experimental Procedures. (B) PKCζ protects SRC-3 from REGγ-mediated proteasome degradation. (C) PKCζ protects SRC-3 from REGγ-mediated proteasome degradation in an in vitro purified system. Purified baculovirus expressed recombinant SRC-3 was phosphorylated by PKCζ in vitro in the presence of ERα and E2. Purified REGγ and 20S proteasome were then added into the reaction and were incubated for an indicated time period.
Fig. 7
Effects of aPKC on ER mediated gene expression and estrogen-dependent cell growth (A) SRC-3 protein level was decreased in MCF-7 (shPKCζ) stable cell line. (B) Knocking-down of PKCζ reduces estrogen-dependent ER target gene transcription. Cells were treated with 10−8 M E2 for 2 hours (c-myc, cycline D1) or overnight (pS2) before being harvested. The transcription were quantified by real time qRT-PCR and normalized against a cyclophilin mRNA level. * indicates p< 0.01. ** indicates p< 0.05. Error bars indicate the standard error of the means from three independent experiments. (C) MTT assay for detecting estrogen-dependent growth of MCF-7. * indicates p< 0.01 (control vs. shPKCζ cells in the presence of E2). Error bars indicate the standard error of the means from triplicate experiments. (D) Estrogen-dependent cell growth by crystal violet staining. Cells were stained with crystal violet after 9 days of growth in medium with or without 10−8 M E2 (Left panel). The Right panel shows the relative cell densities estimated by Scion Image. Shown is the representative result from three independent experiments._(E) Flow cytometry analysis on cell cycle distribution of MCF-7 cells after two days of growth in the presence of 10−7 M E2.
Similar articles
- Atypical regulation of SRC-3.
Garabedian MJ, Logan SK. Garabedian MJ, et al. Trends Biochem Sci. 2008 Jul;33(7):301-4. doi: 10.1016/j.tibs.2008.04.011. Epub 2008 May 24. Trends Biochem Sci. 2008. PMID: 18502645 - Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.
Feng Q, Yi P, Wong J, O'Malley BW. Feng Q, et al. Mol Cell Biol. 2006 Nov;26(21):7846-57. doi: 10.1128/MCB.00568-06. Epub 2006 Aug 21. Mol Cell Biol. 2006. PMID: 16923966 Free PMC article. - Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, Xu J, Kagan BL, Wellstein A, Riegel AT. Oh AS, et al. Mol Cell Biol. 2008 Nov;28(21):6580-93. doi: 10.1128/MCB.00118-08. Epub 2008 Sep 2. Mol Cell Biol. 2008. PMID: 18765637 Free PMC article. - SRC-3/AIB1: transcriptional coactivator in oncogenesis.
Yan J, Tsai SY, Tsai MJ. Yan J, et al. Acta Pharmacol Sin. 2006 Apr;27(4):387-94. doi: 10.1111/j.1745-7254.2006.00315.x. Acta Pharmacol Sin. 2006. PMID: 16539836 Review. - REGgamma: a shortcut to destruction.
Zhou P. Zhou P. Cell. 2006 Jan 27;124(2):256-7. doi: 10.1016/j.cell.2006.01.003. Cell. 2006. PMID: 16439199 Review.
Cited by
- Role of Connexin 43 phosphorylation on Serine-368 by PKC in cardiac function and disease.
Pun R, Kim MH, North BJ. Pun R, et al. Front Cardiovasc Med. 2023 Jan 12;9:1080131. doi: 10.3389/fcvm.2022.1080131. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36712244 Free PMC article. Review. - The role of amplified in breast cancer 1 in breast cancer: A meta-analysis.
Hou J, Liu J, Yuan M, Meng C, Liao J. Hou J, et al. Medicine (Baltimore). 2020 Nov 13;99(46):e23248. doi: 10.1097/MD.0000000000023248. Medicine (Baltimore). 2020. PMID: 33181714 Free PMC article. - Gene-Specific Actions of Transcriptional Coregulators Facilitate Physiological Plasticity: Evidence for a Physiological Coregulator Code.
Stallcup MR, Poulard C. Stallcup MR, et al. Trends Biochem Sci. 2020 Jun;45(6):497-510. doi: 10.1016/j.tibs.2020.02.006. Epub 2020 Mar 13. Trends Biochem Sci. 2020. PMID: 32413325 Free PMC article. Review. - Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway.
Wu Y, Bai X, Li X, Zhu C, Wu ZP. Wu Y, et al. Oncol Lett. 2018 Nov;16(5):6763-6769. doi: 10.3892/ol.2018.9448. Epub 2018 Sep 18. Oncol Lett. 2018. PMID: 30405820 Free PMC article. - Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S, Rajapakshe K, Zhu B, Nikolai BC, Yi P, Putluri N, Choi JM, Jung SY, Coarfa C, Westbrook TF, Zhang XH, Foulds CE, Tsai SY, Tsai MJ, O'Malley BW. Dasgupta S, et al. Nature. 2018 Apr;556(7700):249-254. doi: 10.1038/s41586-018-0018-1. Epub 2018 Apr 3. Nature. 2018. PMID: 29615789 Free PMC article.
References
- Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997;277:965–968. - PubMed
- Cho S, Choi YJ, Kim JM, Jeong ST, Kim JH, Kim SH, Ryu SE. Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7. FEBS Lett. 2001;498:62–66. - PubMed
- Demarest SJ, Martinez-Yamout M, Chung J, Chen H, Xu W, Dyson HJ, Evans RM, Wright PE. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature. 2002;415:549–553. - PubMed
- Donson AM, Banerjee A, Gamboni-Robertson F, Fleitz JM, Foreman NK. Protein kinase C zeta isoform is critical for proliferation in human glioblastoma cell lines. J Neurooncol. 2000;47:109–115. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous